Adjunct immunotherapies for tuberculosis (Q37998000)

26 August 2017

Adjunct immunotherapies for tuberculosis (English)

1 reference

26 August 2017

0 references

1 reference

3

1 reference

26 August 2017

Markus Maeurer

4

0 references

author name string

Michael Uhlin

series ordinal

1

1 reference

PubMed ID

22457298

26 August 2017

Jan Andersson

series ordinal

2

1 reference

PubMed ID

22457298

26 August 2017

language of work or name

English

0 references

publication date

29 March 2012

1 reference

Journal of Infectious Diseases

26 August 2017

1 reference

26 August 2017

205 Suppl 2

1 reference

26 August 2017

S325-34

1 reference

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

26 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Comprehensive treatment of extensively drug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Advances in immunotherapy for tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Genetic dissection of immunity to mycobacteria: the human model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Treatment of infections in the patient with Mendelian susceptibility to mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Treatment of disseminated mycobacterial infection with high-dose IFN-γ in a patient with IL-12Rβ1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

How can immunology contribute to the control of tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Immunomodulatory cytokines as therapeutic agents for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

In vitro differentiation of human macrophages with enhanced antimycobacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Anti-inflammatory actions of intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Thalidomide: tragic past and promising future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Tuberculosis at extremes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Cell-mediated immune responses in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

The role of TGF beta in the pathogenesis of human tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Cellular therapies for lung disease: a distant horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Controlled release of plasmid DNA from hyaluronan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Restoring function in exhausted CD8 T cells during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Interleukin-2 in the development and control of inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Programmed death 1 and cytokine inducible SH2-containing protein dependent expansion of regulatory T cells upon stimulation With Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Requirement for invariant chain in macrophages for Mycobacterium tuberculosis replication and CD1d antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Lipids, apoptosis, and cross-presentation: links in the chain of host defense against Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Exosomes released from M. tuberculosis infected cells can suppress IFN-γ mediated activation of naïve macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Autophagy in the Pathogenesis of Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Hydroxychloroquine modulates metabolic activity and proliferation and induces autophagic cell death of human dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Coadministration of interleukins 7 and 15 with bacille Calmette-Guérin mounts enduring T cell memory response against Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Cutaneous immunosurveillance by self-renewing dermal gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Gammadelta T cells and the lymphoid stress-surveillance response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Interleukin 24 as a novel potential cytokine immunotherapy for the treatment of Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Increased (6 exon) interleukin-7 production after M. tuberculosis infection and soluble interleukin-7 receptor expression in lung tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS197

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIS197

1 reference

26 August 2017

1 reference

PubMed ID

22457298